Stock Market News 24 December 2025

Eos Energy Enterprises Stock (EOSE) Turns Volatile After Chair Transition News as Wall Street Reprices the 2026 Ramp

Eos Energy Enterprises (NASDAQ: EOSE) is heading into the Christmas Eve session with fresh volatility on the tape. Shares closed Tuesday, December 23, 2025 at $11.96, down 7.21%, after the market digested a board leadership transition; pre-market indications early Wednesday, December 24 were modestly higher. With U.S. equities scheduled to close early at 1:00 p.m. ET on Dec. 24, thinner holiday liquidity can amplify price swings—especially for high-beta names like EOSE. StockAnalysis+1 What happened: Eos announces a board chair handoff effective year-end On December 22, 2025, Eos disclosed that Russ Stidolph, its non-executive Chair since 2018 and a long-time investor

24 December 2025

Energy Sector·NASDAQ:EOSE·Stock Market

Strategy Inc Stock MSTR News and Forecasts for December 24, 2025: Cash Reserve Pivot, Bitcoin Pause, and Wall Street Targets

December 24, 2025 — Strategy Inc (Nasdaq: MSTR) is spending Christmas Eve with investors debating a simple but loaded question: is the company’s latest move a prudent de-risking… or a sign that the “leveraged Bitcoin proxy” era is maturing into something more complicated? Shares have been volatile this week, trading around the high-$150s as the market digests fresh disclosures showing no new Bitcoin purchases during the latest reporting window and a sharply higher U.S. dollar cash reserve built from equity sales. MarketBeat+2MarketBeat+2 At the same time, Executive Chairman Michael Saylor is trying to reframe the entire investment story—positioning Strategy not

24 December 2025

Financial Forecasts·NASDAQ:MSTR·Stock Market

United States Antimony Corporation (UAMY) Stock: Today’s Move, Latest Contracts, Analyst Forecasts, and What Investors Are Watching on Dec. 24, 2025

United States Antimony Corporation (NYSE American: UAMY) has become one of the most closely watched “critical minerals” stocks of 2025—partly because antimony has moved from obscure industrial input to strategic flashpoint, and partly because UAMY’s own contract wins and expansion plans have repeatedly jolted the share price. With U.S. markets trading through Wednesday, Dec. 24, 2025 (despite a federal-government closure order that didn’t change exchange schedules), liquidity and headlines are colliding in the classic year-end way: moves can look bigger, faster, and noisier than they would in mid-January. Reuters Below is what’s driving attention around UAMY stock today, what the

24 December 2025

NYSEA:UAMY·Stock Market

Broadcom (AVGO) Stock News Today, Forecasts and Analysis for Dec. 24, 2025: AI Margins, Tariffs, Insider Moves and Valuation

Broadcom Inc. (NASDAQ: AVGO) enters Christmas Eve trading with investors still debating the same two questions that have defined the stock’s volatile December: how durable is the AI-driven demand surge—and how much profitability gets sacrificed to capture it? With U.S. equities markets scheduled to close early at 1:00 p.m. ET today, liquidity is thinner than usual, which can exaggerate moves in high-momentum names like Broadcom. New York Stock Exchange+1 As of the latest available quote on Dec. 24, Broadcom shares were hovering around the $349–$350 area, after a strong prior session. MarketWatch Why Broadcom stock is still a headline name

24 December 2025

Financial Forecasts·NASDAQ:AVGO·Stock Market

Teva Stock News on Dec. 24, 2025: TEVA Rallies on S&P Credit Upgrade, $40 Price Target Hike, and Fresh Pipeline Catalysts

Teva Pharmaceutical Industries Limited (NYSE: TEVA; TASE: TEVA) stock is finishing 2025 with unusual momentum for a company long labeled “just a generics maker.” On Dec. 24, 2025, TEVA is trading around the $31–$32 range after a sharp run-up over the past several weeks, with holiday-thinned markets now digesting a cluster of developments that bulls say strengthen Teva’s “pivot to growth” story—and bears say risk turning into a valuation trap. StockAnalysis+1 This is the key backdrop: credit conditions are improving, analysts are lifting targets, and Teva’s pipeline/biosimilars calendar is getting clearer—all while the company is still navigating the industry’s classic

24 December 2025

NYSE:TEVA·Pharmaceuticals·Stock Market

Rezolute, Inc. (RZLT) Stock News and Forecasts on Dec. 24, 2025: Phase 3 sunRIZE Miss, Analyst Target Cuts, and What Comes Next

Rezolute, Inc. (Nasdaq: RZLT) is still in the spotlight on December 24, 2025, after a brutal mid-December selloff tied to its pivotal clinical trial news—and a wave of follow-on analyst downgrades, price-target resets, and investor-law-firm investigations. As of the latest available pricing around $2.42 per share, the stock is off its post-trial lows but remains dramatically below pre-readout levels, leaving investors weighing a simple question with complicated consequences: was sunRIZE a fatal blow, or a detour that shifts the story toward Rezolute’s next late-stage program? MarketBeat+1 Below is a complete, publication-ready breakdown of the current RZLT stock news, forecasts, and

24 December 2025

Financial Forecasts·NASDAQ:RZLT·Stock Market

Chick-fil-A Set to Return to Portland in Early 2026 at Former Strip Club Near Mall 205, as Christmas Eve Dining Hours Go Top of Mind

PORTLAND, Ore. — December 24, 2025. On a day when millions of Americans are asking the same practical question — “What’s open on Christmas Eve and Christmas Day?” — Portland is also buzzing about a very different kind of food-and-hours headline: Chick-fil-A is preparing to return to Portland proper for the first time in roughly two decades, with an early 2026 opening now being touted for a high-profile site in Southeast Portland. KGW The new restaurant is slated for the former Venue Gentleman’s Club property on Southeast Stark Street, just north of Mall 205 — a location that has already

24 December 2025

Stock Market

Dollarama Stock (TSX: DOL) Near Fresh Highs on Dec. 24, 2025: Earnings Momentum, Global Expansion, and a Valuation Test

Dollarama is ending 2025 in the spotlight as investors weigh a familiar question with an unusually sharp edge: how much is too much to pay for a business that keeps delivering? On December 24, 2025, the discussion is unfolding against a holiday-thinned trading session in Canada—markets are scheduled to close early—after the S&P/TSX set new records and heads toward its best annual performance since 2009. Reuters At the stock level, Dollarama has been pressing toward the upper end of its recent range, closing around C$204.69 in the latest session cited by multiple market trackers—right where the latest valuation commentary is

24 December 2025

Earnings Reports·Stock Market·TSX:DOL

Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is in the spotlight on December 24, 2025 after a sharp selloff driven by a major regulatory development: the U.S. Food and Drug Administration recommended that Reviva run an additional Phase 3 trial for its lead schizophrenia candidate, brilaroxazine, before filing a New Drug Application (NDA). SEC+1 Shares were trading around $0.32 after the drop, reflecting how quickly biotech valuations can reprice when timelines and funding needs change—especially for micro-cap clinical-stage companies. StockAnalysis What happened to Reviva Pharmaceuticals stock on December 24, 2025? The core catalyst is a regulatory “reset” of the near-term approval

24 December 2025

Financial Forecasts·NASDAQ:RVPH·Pharmaceuticals·Stock Market

Regencell Bioscience Holdings Limited (RGC) Stock: News, Forecasts, and Fresh Analysis for Dec. 24, 2025

Dec. 24, 2025 — Regencell Bioscience Holdings Limited (NASDAQ: RGC) is having one of those “stock market is a strange animal” moments again: the share price is moving sharply on a story dominated less by traditional fundamentals and more by market structure—low float, extreme volatility, and ongoing legal overhang. As of Dec. 24, 2025, RGC was trading around $25.25, up roughly 14% on the day. Below is a complete, publication-ready roundup of what’s new today (12/24/2025), what the most current forecasts/models are implying, and what the latest filings and third‑party analysis say about the risks that keep following this stock

24 December 2025

Biotechnology·NASDAQ:RGC·Stock Market

Stock Market Today: U.S. Futures Dip on Christmas Eve as S&P 500 Holds Record High and GDP Surprise Trims Rate‑Cut Bets

Wall Street is heading into Christmas Eve trading (Wednesday, December 24, 2025) with a familiar holiday mix: thin liquidity, an early close, and outsized market attention on macro headlines after the S&P 500 finished Tuesday at a fresh record. U.S. stock index futures were modestly lower in premarket action, as traders weighed an unexpectedly strong U.S. growth reading against stubborn inflation signals that are complicating the path for Federal Reserve rate cuts in 2026. Reuters+2Reuters+2 This year’s story has also been shaped by a unique wrinkle: several key government economic releases were delayed by a federal shutdown, meaning investors have

24 December 2025

Stock Market

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth Corporation (NASDAQ: CGC, TSX: WEED) is ending 2025 with something cannabis stocks haven’t seen in a while: sustained, headline-driven volatility — the kind that can lift prices fast, then yank them back down just as quickly. As of Dec. 24, 2025, CGC was trading around $1.40 in U.S. markets, after closing at $1.40 on Dec. 23 and showing a modest uptick in early premarket indications. StockAnalysis That price tag doesn’t tell the story by itself. December’s story is about policy momentum in Washington, a fresh Canadian acquisition announcement, and a market that’s still trying to decide whether Canopy

24 December 2025

Cannabis Industry·Financial Forecasts·NASDAQ:CGC·Stock Market·TSX:WEED

Previous 1 … 1,067 1,068 1,069 1,070 1,071 … 1,947 Next

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

7 February 2026

Google raised its 2026 capital expenditure forecast to $175 billion–$185 billion, with most spending expected on data-center chips. Broadcom shares rose about 2% after the announcement, while Nvidia and AMD slipped. Jefferies reiterated a buy rating on Broadcom, maintaining a $500 price target, implying a 62% upside from Wednesday’s close.

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026

The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.

Tesla stock price rises to $411 as Musk solar hiring push and China AI plan set up week ahead

7 February 2026

Tesla shares closed up 3.5% at $411.11 on Friday after news of a U.S. solar hiring push and an AI training center in China. The company targets 100 GW of U.S. solar manufacturing by 2028, far above current national output. Investors remain focused on Tesla’s autonomy and energy projects. Upcoming U.S. jobs and inflation data may affect market sentiment next week.

Palantir stock price rebounds to $135.90 on Cognizant AI deal — what to watch next week

7 February 2026

Palantir shares closed Friday at $135.90, up 4.5% after Cognizant’s TriZetto unit announced plans to deploy Palantir Foundry and AIP in healthcare and business-process operations. The Dow closed above 50,000 for the first time. U.S. jobs and inflation data due next week may shift rate expectations for high-growth software stocks.